What is the recommended dosage of Zosyn (piperacillin/tazobactam) and are there potential interactions with a condition or medication referred to as masa?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended dosage of Zosyn (piperacillin/tazobactam) is 4.5 g administered intravenously every 6-8 hours for adults with normal renal function, as per the most recent guidelines 1.

Dosage and Administration

The dosage of Zosyn can range from 3.375 to 4.5 grams administered intravenously every 6-8 hours for adults with normal renal function. However, the most recent and highest quality study recommends 4.5 g every 6-8 hours 1. Dosage adjustments are necessary for patients with impaired kidney function, with reductions based on creatinine clearance levels.

Potential Interactions with "Masa"

There are no known specific interactions between Zosyn and a condition or medication called "masa." However, it's essential to note that "masa" is not a recognized medical condition or medication in standard medical terminology. If "masa" refers to a specific medication, food, or condition in another context, consultation with a healthcare provider is crucial before starting Zosyn therapy.

Mechanism of Action and Treatment Duration

Zosyn may interact with certain medications, including probenecid, aminoglycosides, and anticoagulants. The medication works by combining piperacillin, a penicillin antibiotic, with tazobactam, which prevents bacterial resistance by inhibiting beta-lactamase enzymes. Treatment duration typically ranges from 7-14 days, depending on the type and severity of infection being treated, as supported by guidelines from the Infectious Diseases Society of America 1 and other recent studies 1.

Key Considerations

  • The medication should be used with caution in patients with a history of penicillin allergy or renal impairment.
  • Monitoring of renal function and adjustment of dosage as needed is crucial.
  • Zosyn is effective against a wide range of bacterial infections, including those caused by extended-spectrum beta-lactamase (ESBL) producing organisms, as indicated in recent clinical guidelines 1.

From the FDA Drug Label

2.1 Dosage in Adult Patients with Indications Other Than Nosocomial Pneumonia The usual total daily dosage of piperacillin and tazobactam for injection for adult patients with indications other than nosocomial pneumonia is 3.375 g every six hours [totaling 13.5 g (12 g piperacillin and 1.5 g tazobactam)], to be administered by intravenous infusion over 30 minutes.

The recommended dosage of Zosyn (piperacillin/tazobactam) is 3.375 g every six hours for adult patients with indications other than nosocomial pneumonia. There is no information about potential interactions with a condition or medication referred to as masa in the provided drug labels 2 2.

From the Research

Zosyn (Piperacillin/Tazobactam) Dosage

  • The recommended dosage of Zosyn (piperacillin/tazobactam) is not explicitly stated in the provided studies, but its effectiveness in various infections is discussed 3, 4, 5.
  • Piperacillin/tazobactam is administered in an 8:1 ratio and has been shown to be effective in treating lower respiratory tract, intra-abdominal, urinary tract, gynaecological, and skin/soft tissue infections, as well as fever in patients with neutropenia 3.

Potential Interactions with Masa

  • There is no direct information available on potential interactions between Zosyn (piperacillin/tazobactam) and a condition or medication referred to as "masa" in the provided studies.
  • However, piperacillin/tazobactam has been shown to be effective in treating various infections, including those caused by Gram-positive and Gram-negative aerobic and anaerobic bacteria, and its use in combination with other antibiotics, such as aminoglycosides, has been discussed 3, 4, 6.
  • The studies also mention the importance of considering factors such as the isolate's MIC, the site and severity of infection, and the type of resistance mechanism when choosing an antibiotic regimen, including piperacillin/tazobactam 6, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.